Yinchen Wuling San ameliorates high-fat diet-induced metabolic-associated fatty liver disease in rats by remodeling the gut microbiota

Figure 3 The effect of Yinchen Wuling San on body weight, hepatic function, and fat buildup in metabolic-associated fatty liver disease rats (n = 6). A: Changes in the body mass of the rats in each group; B: Liver index; C: Alanine aminotransferase; D: Aspartate aminotransferase; E: Total cholesterol; F: Triglycerides; G: Low-density lipoprotein cholesterol; H: High-density lipoprotein cholesterol. The data are shown as the mean ± SD. ^bP < 0.01 vs control, ^dP < 0.01 vs model. YCWLS: Yinchen Wuling San; CBLT: Bifidobacterium quadruple live bacteria tablets; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; TC: Total cholesterol; TG: Triglycerides; LDL-C: Low-density lipoprotein cholesterol; HDL-C: High-density lipoprotein cholesterol.